ReviewJournal of hematology & oncology2021
Prostate cancer and PARP inhibitors: progress and challenges.
Diego Teyssonneau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
89 papers cite itlatest 60 shown
this paperpooled ittrialcites it